<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04176783</url>
  </required_header>
  <id_info>
    <org_study_id>9120</org_study_id>
    <nct_id>NCT04176783</nct_id>
  </id_info>
  <brief_title>Opioid-Free Orthopaedic Surgery</brief_title>
  <acronym>CORE</acronym>
  <official_title>Carolina's Opioid Reduction Effort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OrthoCarolina Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OrthoCarolina Research Institute, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and effectiveness of two pain control pathways following routine&#xD;
      orthopaedic surgical procedures (single level or two-level ACDF/ACDA, 1st CMC arthroplasty,&#xD;
      Hallux Valgus/Rigidus corrections, diagnostic knee arthroscopies, total hip arthroplasty, and&#xD;
      total shoulder arthroplasty / reverse total shoulder arthroplasty). The control group will&#xD;
      undergo surgery with an opioid-based pain protocol and the intervention group will undergo&#xD;
      surgery with a multimodal, opioid-free protocol.&#xD;
&#xD;
      Patients will have data collected with respect to pain scores, overall comfort level, overall&#xD;
      satisfaction with the surgical experience and recovery, constipation, falls, and overall&#xD;
      satisfaction with pain control, in addition to procedure-specific outcome scores and&#xD;
      patient-specific metrics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">April 16, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 17, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at 24 hours postop</measure>
    <time_frame>24 hours</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at 6 hours postop</measure>
    <time_frame>6 hours</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at 12 hours postop</measure>
    <time_frame>12 hours</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at 2 weeks postop</measure>
    <time_frame>2 weeks</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at 6 weeks postop</measure>
    <time_frame>6 weeks</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at 1 year postop</measure>
    <time_frame>1 year</time_frame>
    <description>Numeric Pain Rating Scale 0-10, with 10 representing the highest/worst pain score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Health</measure>
    <time_frame>1 year</time_frame>
    <description>Veterans Rand-12</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>Opioid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The opioid-based arm utilizes traditional, standard-of-care treatment for each applicable surgery. The medications (including dosage and frequency) used in this arm vary depending on the surgery being performed; however, tend to include medications in the opioid family such as Hydromorphone, Hydrocodone, Tramadol, or Oxycodone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid-Free</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The opioid-free arm utilizes medications that do not belong to the opioid family of medications. All medications used are FDA-approved and no experimental medications are being used. The medications (including dosage and frequency) used in this arm vary depending on the surgery being performed; however, tend to include medications such as Gabapentin, Tylenol, Meloxicam, Bupivacaine, or Ketorolac.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioids</intervention_name>
    <description>narcotic pain medicine</description>
    <arm_group_label>Opioid</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioid-Free</intervention_name>
    <description>non narcotoc pain medication</description>
    <arm_group_label>Opioid-Free</arm_group_label>
    <other_name>Intervention</other_name>
    <other_name>Non-Opioid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        1. Patient is scheduled to undergo one of the following procedures:&#xD;
&#xD;
          -  Primary single-level or two-level ACDF or ACDA for degenerative disease&#xD;
&#xD;
          -  Primary 1st CMC arthroplasty&#xD;
&#xD;
          -  Primary Hallux Valgus or Hallux Rigidus correction&#xD;
&#xD;
          -  Diagnostic knee arthroscopy +/- meniscal debridement&#xD;
&#xD;
          -  Elective primary total shoulder or reverse total shoulder arthroplasty&#xD;
&#xD;
          -  Primary total hip arthroplasty&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Revision surgery for one of the study-specific procedures&#xD;
&#xD;
          2. Chronic opioid therapy - per investigator discretion&#xD;
&#xD;
          3. Significant liver disease - (NOTE: Patients with a history of liver disease will have&#xD;
             a hepatic panel drawn to be reviewed by the study investigator to asses if the values&#xD;
             are within acceptable limits for inclusion in the study)&#xD;
&#xD;
          4. Fracture or soft tissue injury&#xD;
&#xD;
          5. Sickle cell disease&#xD;
&#xD;
          6. Workers compensation&#xD;
&#xD;
          7. Alcohol dependence&#xD;
&#xD;
          8. Contra-indication to regional anesthesia&#xD;
&#xD;
          9. History of gastrointestinal (GI) bleeding or peptic ulcer&#xD;
&#xD;
         10. History of bleeding problems&#xD;
&#xD;
         11. Patients taking anticoagulants, not including aspirin (only applies to Randomized&#xD;
             portion of study. These patients can still participate in Observational Control Group)&#xD;
&#xD;
         12. Renal insufficiency - Creatinine clearance less than 30 mL/min (only applies to&#xD;
             patients having surgery requiring NSAIDs treatment)&#xD;
&#xD;
         13. Outpatient THA or TSA/RTSA&#xD;
&#xD;
         14. Hammertoe in isolation (Hallux Valgus/Rigidus exclusion only)&#xD;
&#xD;
         15. Concomitant meniscal repair or microfracture (Knee Arthroscopy exclusion only)&#xD;
&#xD;
         16. Ineligible for spinal anesthesia (THA exclusion only)&#xD;
&#xD;
         17. Previous ipsilateral hip surgery, not including hip scope (THA exclusion only)&#xD;
&#xD;
         18. Allergy to non-steroidal anti-inflammatory medications (NSAIDs)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nady M Hamid, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OrthoCarolina Research Institute, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OrthoCarolina, P.A.</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 16, 2018</study_first_submitted>
  <study_first_submitted_qc>November 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2019</study_first_posted>
  <last_update_submitted>August 17, 2020</last_update_submitted>
  <last_update_submitted_qc>August 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

